Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris

Completed · Phase 2

Conditions studied: Acne Vulgaris

In brief

Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris

Key facts

Study ID

NCT03003247

Run by

Bausch Health Americas, Inc.

People needed

364

Starts

2015-11-01

Expected to finish

2016-09-30

Last updated by the study team

2017-12-18

Who can join

Age: 9 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

• Valeant Site 15 — Encino, California, United States
• Valeant Site 13 — Lake Mary, Florida, United States
• Valeant Site 16 — Miami, Florida, United States
• Valeant Site 14 — Tampa, Florida, United States
• Valeant Site 02 — West Palm Beach, Florida, United States
• Valeant Site 21 — Atlanta, Georgia, United States
• Valeant Site 23 — South Bend, Indiana, United States
• Valeant Site 09 — Detroit, Michigan, United States
• Valeant Site 24 — Minneapolis, Minnesota, United States
• Valeant Site 11 — Saint Joseph, Missouri, United States
• Valreant Site 05 — New York, New York, United States
• Valeant Site 06 — New York, New York, United States
• Valeant Site 01 — Chapel Hill, North Carolina, United States
• Valeant Site 17 — High Point, North Carolina, United States
• Valeant Site 22 — Columbus, Ohio, United States
• Valeant Site 04 — Knoxville, Tennessee, United States
• Valeant Site 07 — Austin, Texas, United States
• Valeant Site 12 — Austin, Texas, United States
• Valeant Site 18 — San Antonio, Texas, United States
• Valeant Site 25 — Spokane, Washington, United States
• Valeant Site 10 — Winnepeg, Manitoba, Canada
• Valeant Site 03 — Markham, Ontario, Canada
• Valeant Site 08 — Waterloo, Ontario, Canada
• Valeant Site 20 — Windsor, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.